Literature DB >> 26572807

Tetramer formation of tumor suppressor protein p53: Structure, function, and applications.

Rui Kamada1, Yu Toguchi1, Takao Nomura2, Toshiaki Imagawa1, Kazuyasu Sakaguchi1.   

Abstract

Tetramer formation of p53 is essential for its tumor suppressor function. p53 not only acts as a tumor suppressor protein by inducing cell cycle arrest and apoptosis in response to genotoxic stress, but it also regulates other cellular processes, including autophagy, stem cell self-renewal, and reprogramming of differentiated cells into stem cells, immune system, and metastasis. More than 50% of human tumors have TP53 gene mutations, and most of them are missense mutations that presumably reduce tumor suppressor activity of p53. This review focuses on the role of the tetramerization (oligomerization), which is modulated by the protein concentration of p53, posttranslational modifications, and/or interactions with its binding proteins, in regulating the tumor suppressor function of p53. Functional control of p53 by stabilizing or inhibiting oligomer formation and its bio-applications are also discussed.
© 2015 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 598-612, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  bio-nanomaterials; cancer; oligomerization; structure; tumor suppressor

Mesh:

Substances:

Year:  2016        PMID: 26572807     DOI: 10.1002/bip.22772

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  33 in total

1.  PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.

Authors:  R-K Li; J- Gao; L-H Guo; G-Q Huang; W-H Luo
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

2.  A new era of studying p53-mediated transcription activation.

Authors:  Wei-Li Liu; Robert A Coleman; Sameer K Singh
Journal:  Transcription       Date:  2017-10-04

Review 3.  How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

Authors:  Brandon J Aubrey; Gemma L Kelly; Ana Janic; Marco J Herold; Andreas Strasser
Journal:  Cell Death Differ       Date:  2017-11-17       Impact factor: 15.828

4.  AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts.

Authors:  Qing Li; Qiu-Ting Dong; Yue-Jin Yang; Xia-Qiu Tian; Chen Jin; Pei-Sen Huang; Lei-Pei Jiang; Gui-Hao Chen
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.

Authors:  Yi-Wen Chang; Chia-Lang Hsu; Cheng-Wei Tang; Xiang-Jun Chen; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Mol Cell Proteomics       Date:  2020-08-11       Impact factor: 5.911

6.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

7.  ZNF280B promotes the growth of gastric cancer in vitro and in vivo.

Authors:  Jingming Zhai; Zheng Yang; Xiaodong Cai; Guoliang Yao; Yanhui An; Wei Wang; Yonggang Fan; Chao Zeng; Kefeng Liu
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

Review 8.  Should mutant TP53 be targeted for cancer therapy?

Authors:  Andreas Strasser; Gemma L Kelly; Zilu Wang
Journal:  Cell Death Differ       Date:  2022-03-24       Impact factor: 12.067

9.  Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.

Authors:  Viola Ellison; George K Annor; Clara Freedman; Gu Xiao; Devon Lundine; Elzbieta Freulich; Carol Prives; Jill Bargonetti
Journal:  Oncotarget       Date:  2021-06-08

Review 10.  Confocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical Guide.

Authors:  Yann Gambin; Mark Polinkovsky; Bill Francois; Nichole Giles; Akshay Bhumkar; Emma Sierecki
Journal:  Int J Mol Sci       Date:  2016-04-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.